Watson Fund
5
19M
5
1
- Areas of investment
Summary
The venture was found in North America in United States. The main department of described VC is located in the Seattle.
The top activity for fund was in 2016. The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 10 - 50 millions dollars.
Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has exact preference in some founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Wellness, Therapeutics. Among the most popular portfolio startups of the fund, we may highlight Rodeo Therapeutics, ApoGen Biotechnologies, Magnolia NeuroSciences.
The typical case for the fund is to invest in rounds with 9 participants. The meaningful sponsors for the fund in investment in the same round are Johnson & Johnson Innovation, ARCH Venture Partners, WuXi AppTec. In the next rounds fund is usually obtained by M Ventures.
Investments analytics
Analytics
- Total investments
- 5
- Lead investments
- 0
- Exits
- 1
- Investments by industry
- Biotechnology (5)
- Pharmaceutical (4)
- Health Care (4)
- Therapeutics (2)
- Wellness (1) Show 2 more
- Investments by region
-
- United States (5)
- Peak activity year
- 2016
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Avg. valuation at time of investment
- 11M
- Group Appearance index
- 1.00
- Avg. company exit year
- 4
- Avg. multiplicator
- 3.69
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Proniras Corp | 01 Feb 2024 | Biotechnology, Health Care, Life Science, Pharmaceutical | Early Stage Venture | 4M | United States, Washington, Seattle |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.